Reduced liver function is the trigger for renal sodium retention following portal vein ligation in the rat

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 9, 1996, Pages 850-856

  Murakami, Shigeto ^a,b   Ohno, Toshiyuki ^a   Bernardo, José F ^a   Pfeifer, Cynthia A ^a   Li, Timeo ^a   Zhang, Yong ^a   Dubey, Raghvendra K ^a   Branch, Robert A ^a   Sabra, Ramzi ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aminopyrine metabolism; Hydralazine; Partial portal vein ligation; Peripheral vasodilation; Sodium retention

Indexed keywords

HYDRALAZINE;

ANIMAL EXPERIMENT; ARTICLE; LIVER FAILURE; NONHUMAN; ORAL DRUG ADMINISTRATION; PORTAL VEIN; PRIORITY JOURNAL; SODIUM RETENTION; VASODILATATION; VEIN LIGATION;

EID: 0029798321     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00092.x     Document Type: Article

References (23)

1. Wensing G, Sabra R, Branch RA. The onset of sodium retention in experimental cirrhosis in rats is related to a critical threshold of liver function. Hepatology 1990; 11: 779-86.
2. Wensing G, Branch RA. Phenobarbital influences the development of sodium retention in liver disease induced by bile duct ligation in the rat. Hepatology 1990; 11: 773-8.
3. Liebermann FL, Denison EK, Reynolds TB. The relationship of plasma volume, portal hypertension, ascites, and renal sodium retention in cirrhosis: The 'overflow' theory of ascites formation. Ann. N.Y. Acad. Sci. 1970; 170: 202-6.
4. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 831-6.
5. Ohno T, Sabra R, Branch RA. Sodium retention and hepatic function after two-thirds hepatectomy in the rat. Hepatology 1991; 14: 511-17.
6. Ohno T, Branch RA, Sabra R. Sodium retention and hepatic function following partial portal vein ligation in the rat. J. Hepatol. 1993; 18: 235-43.
7. Lauterburg BH, Bircher J. Expiratory measurement of maximal aminopyrine demethylation in vivo: Effect of phenobarbital, partial hepatectomy, porto-caval shunt, and bile duct ligation in the rat. J. Pharmacol. Exp. Ther. 1976; 196: 501-9.
8. Gross JB, Reichen J, Zeltner TB, Zimmermann A. The evolution of changes in quantitative liver function tests in rat model of biliary cirrhosis: Correlation with morphometric measurement of hepatocyte mass. Hepatology 1987; 7: 457-63.
9. Reichen J, Arts B, Schafroth U, Zimmermann A, Zeltner ThB, Zysset T. Aminopyrine N demethylation by rats with liver cirrhosis: Evidence for intact cell hypothesis. A morphometric-functional study. Gastroenterology 1987; 93: 719-26.
10. Schuster L, Seldin DW. Renal clearance. In: Seldin DW, Giebisch G, eds. The Kidney: Physiology and Pathophysiology, vol. 1. New York: Raven Press, 1985; 365-95.
11. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal-hypertensive rat model: A primary factor for maintenance of chronic portal hypertension. Am. J. Physiol. 1983; 244: G52-7.
12. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am. J. Physiol. 1989; 248: G618-25.
13. Levy M, Allotey JB. Temporal relationship between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis. J. Lab. Clin. Med. 1978; 92: 560-9.
14. Levy M. Sodium retention and ascites formation in dogs with experimental portal cirrhosis. Am. J. Physiol. 1977; 233: F572-85.
15. Schedl HP, Bartter FC. An explanation for and experimental correction of the abnormal water diuresis in cirrhosis. J. Clin. Invest. 1960; 39: 248-61.
16. Hlahcevic ZR, Adam NF, Jick H, Moore EW, Chalmers TC. Renal effects of acute expansion of plasma volume in cirrhosis. N. Engl. J. Med. 1965; 272: 387-91.
17. Gornel DL, Lancestremere RG, Papper S, Lowenstein LM. Acute changes in renal excretion of water and solute in patients with Laennec's cirrhosis induced by the infusion of the pressor amine, metaraminol. J. Clin. Invest. 1962; 41: 594-603.
18. Epstein M. Renal sodium handling in liver disease. In: Epstein M, ed. The Kidney in Liver Disease, 3rd edn. Baltimore: Williams and Wilkins, 1988; 3-30.
19. Colombato LA, Albillos A, Groszmann RJ. Temporal relationship of peripheral vasodilation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats. Hepatology 1991; 15: 323-8.
20. Albillos A, Colombato LA, Groszmann RJ. Vasodilation and sodium retention in prehepatic portal hypertension. Gastroenterology 1992; 102: 931-5.
21. Albillos A, Colombato LA, Lee F, Groszmann RJ. Octreotide ameliorates vasodilation and sodium retention in portal hypertensive rats. Gastroenterology 1993; 104: 575-9.
22. Arendshorst WJ, Gabriel Sodiumvar L. Renal circulation and glomerular hemodynamics. In: Schrier RW, Gottschalk CW, eds. Diseases of the Kidney, 5th edn. Boston: Little Brown, 1993; 65-117.
23. Packer M, Meller J, Medina N, Yushak M, Gorlin R. Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure. N. Engl. J. Med. 1982; 306: 57-62.